ALCYONE CLN3 gene therapy

· Alcyone Therapeutics, Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for ALCYONE CLN3 gene therapy, covering 2025-08-07 to 2025-08-07. Get the full timeline:

Most recent: Clinical Trial Update: Gene Therapy for Children With CLN3 Batten Disease [Phase 1, Phase 2]